<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3436AFC-51A8-400A-B98A-2F29F0933745"><gtr:id>E3436AFC-51A8-400A-B98A-2F29F0933745</gtr:id><gtr:name>Capital Medical University</gtr:name><gtr:address><gtr:line1>8 Xitou Tiao</gtr:line1><gtr:line2>Touan men wai</gtr:line2><gtr:line3>FengTai District</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8F4D4E4F-055E-4A6B-B5A9-C73A9C2420A6"><gtr:id>8F4D4E4F-055E-4A6B-B5A9-C73A9C2420A6</gtr:id><gtr:name>Xinjiang Medical University</gtr:name><gtr:address><gtr:line1>Xinjiang Medical University</gtr:line1><gtr:line2>Xinyi Road 393</gtr:line2><gtr:line3>830011</gtr:line3><gtr:postCode>830011</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3436AFC-51A8-400A-B98A-2F29F0933745"><gtr:id>E3436AFC-51A8-400A-B98A-2F29F0933745</gtr:id><gtr:name>Capital Medical University</gtr:name><gtr:address><gtr:line1>8 Xitou Tiao</gtr:line1><gtr:line2>Touan men wai</gtr:line2><gtr:line3>FengTai District</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8F4D4E4F-055E-4A6B-B5A9-C73A9C2420A6"><gtr:id>8F4D4E4F-055E-4A6B-B5A9-C73A9C2420A6</gtr:id><gtr:name>Xinjiang Medical University</gtr:name><gtr:address><gtr:line1>Xinjiang Medical University</gtr:line1><gtr:line2>Xinyi Road 393</gtr:line2><gtr:line3>830011</gtr:line3><gtr:postCode>830011</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EE698B07-6C45-47E9-A637-420AD61D5494"><gtr:id>EE698B07-6C45-47E9-A637-420AD61D5494</gtr:id><gtr:firstName>Tao</gtr:firstName><gtr:surname>Dong</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001046"><gtr:id>C24E4CF6-8395-4FB1-A319-CD4D1856AF14</gtr:id><gtr:title>Virus specific memory T cell responses in H5N1 avian influenza virus infected patients</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001046</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The threat of H5N1 avian influenza infection in humans has become a serious concern. In this study we intend to measure the H5N1 avian influenza virus specific T cell responses and cross reactive T memory cell responses in both acute and convalescent patients in Vietnam. We will monitor the functional changes in T cell memory pools longitudinally, and to study if the quality of the dominant T cell responses has an impact in clinical outcome of H5N1 human infection. We will also examine T cell responses in people who have been exposed to avian influenza virus but who have apparently been not ill, looking for evidence of subclinical infection.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>59151</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Capital University of Medical Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Mapping HBV epitopes</gtr:description><gtr:id>180B31C0-44C7-408F-BE9E-CD4CF14F1A18</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>56c5c65b9038d3.40361217-1</gtr:outcomeId><gtr:partnerContribution>Grant from Minister of Science and technology, Youan hospital internal funds for patient recruitment, and immunology core facility, consumables (total CNY 5000000)</gtr:partnerContribution><gtr:piContribution>Grant from Janssen pharmaceutical (1000000USD) and MRC HIU core support</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Xinjiang Medical University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>TAA specific T cell responses in cancer patients</gtr:description><gtr:id>79D0BDB3-9512-4552-830C-79892744F2D2</gtr:id><gtr:impact>One paper published on HLA association with EBV associated NPC (Immunology 2014), more to come. Joint funding from NSFC, Minister of Science and Technology China and MRC HIU core)</gtr:impact><gtr:outcomeId>56c5c45e842c29.99679921-1</gtr:outcomeId><gtr:partnerContribution>Joint grant application, patient recruitment, blood nab samples, local technique support, local ethic applications etc.</gtr:partnerContribution><gtr:piContribution>Design and performed experiments, wrote research proposal together, training local researchers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Capital University of Medical Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Youan Infectious Diseases Hospital</gtr:department><gtr:description>Influenza specific T cell responses in influenza virus infection in China</gtr:description><gtr:id>D4BA95DA-EEB2-48D3-991B-9AEE346DE69A</gtr:id><gtr:impact>paper in preparation</gtr:impact><gtr:outcomeId>fgv4EaSic5c-1</gtr:outcomeId><gtr:partnerContribution>Performed large part of the experiments</gtr:partnerContribution><gtr:piContribution>Direct the study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Jenner Institute</gtr:department><gtr:description>Flu vaccine for heterosubtypeic protection</gtr:description><gtr:id>1929738B-65FA-4FD8-ACB0-7DB29FFBC681</gtr:id><gtr:impact>2 paper submitted</gtr:impact><gtr:outcomeId>N1X638RK5cd-1</gtr:outcomeId><gtr:partnerContribution>Access to patient cohort after flu challenge, enable us to study the role of pre-existing T cells in contributing to the protection and disease outcome.</gtr:partnerContribution><gtr:piContribution>Expertise in T cell study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk for World AIDS DAY 2014, St Edmund Hall</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>326A037E-A855-412E-AD3B-1662A605E0F7</gtr:id><gtr:impact>Ms Sophie Andrews who Professor Dong is a supervisor of did a talk which sparked questions and discussion afterwards.

n/a</gtr:impact><gtr:outcomeId>547c3ba7f1dab6.17438037</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast on University Website</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C7C37CA3-E9AC-4875-AEE8-4D01387F52AE</gtr:id><gtr:impact>A podcast on Infectious diseases in China

n/a</gtr:impact><gtr:outcomeId>546492f578c1d1.12840565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ndm.ox.ac.uk/tao-dong-infectious-diseases-in-china</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gene responsible for increased severity of influenza in Chinese populations, published online in the MRC network magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D89A5F91-36DF-4F4D-AE6A-BB152363BBC5</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>5464948d5315b8.09334553</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/news-events/news/gene-responsible-for-increased-severity-of-influenza-in-chinese-populations/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science Interview, posted online</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE2591C7-17AA-422B-BECB-7521C5C1290E</gtr:id><gtr:impact>A project on 'Experiences of Women in Science at the University of Oxford'. It has been funded by the Vice-Chancellor's Diversity Fund. One of the primary aims of the new Fund is to address the under-representation of women in senior research and academic posts. The aim of this project is to develop a University of Oxford website based on interviews with women scientists at different stages of their careers.</gtr:impact><gtr:outcomeId>56c6dc5ad951f0.27800448</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford High School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>03AC00C7-2F8D-43DF-9C8A-7DB664D568E4</gtr:id><gtr:impact>Talk on HIV and AIDS in Africa

The talk heightened the understanding of HIV and AIDS</gtr:impact><gtr:outcomeId>54632d39020395.17713338</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gene linked to more severe flu in Chinese populations</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>75CDB7D9-2DE1-4A34-A5E1-65E4A2DFCE34</gtr:id><gtr:impact>Online news segment explaining the genetic variant which explains why Chinese populations may be more vulnerable to H1N1 swine flu has been found by researchers at the University of Oxford and Beijing Capital Medical University.

n/a</gtr:impact><gtr:outcomeId>5464940c2988b3.45166105</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ox.ac.uk/news/2013-01-29-gene-linked-more-severe-flu-chinese-populations</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Plymouth University about PhD life and Career Options</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DF62768F-1CE5-44D2-A8A9-F4F05B2B711A</gtr:id><gtr:impact>Dr Dannielle Wellington, part of Professor Dong'd group have a talk to Plymouth University undergraduate students about PhD life and career options in a Q &amp;amp; A session.</gtr:impact><gtr:outcomeId>58bffc15368a20.59881298</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Festival of Science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>556CCB84-EF6D-4B9A-A266-41F25DDC8F07</gtr:id><gtr:impact>Kerry Kite, Research Assistant in Prof. Dong's group took part in the MRC Festival of Science. The aim was to interact with the public outside a local supermarket in Whitney. We wanted to explain the work the MRC does involving genetically engineering viruses to kill cancerous cells. The impact was to show the public, who's tax money goes towards our funding, our work and explain it to them in a way they can understand. We spoke to children, teenagers and adults of various backgrounds. They played games and won chocolates and freebies as well as the chance to ask many questions and discuss other areas of science they were interested in.</gtr:impact><gtr:outcomeId>58bff86d9c2f31.91102396</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Beijing-UK Emerging Infectious Disease symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4CE56C53-6E50-457B-9221-B10DE4556034</gtr:id><gtr:impact>Talks between Beijing and UK delegates sparked talks and discussions afterwards.

Talks encouraged more collaborations between Beijing and UK.</gtr:impact><gtr:outcomeId>546496fe8524c4.16235043</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lab tour for Dutch college students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53EB90A7-65D2-4952-9012-14A2ACD126C7</gtr:id><gtr:impact>Dr Dannielle Wellington, part of Prof. Dong's group conducted a lab tour for Dutch college students and answered their questions about career and University</gtr:impact><gtr:outcomeId>58bffca5d69512.93057315</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2800000</gtr:amountPounds><gtr:country>China, People's Republic of</gtr:country><gtr:currCode>CNY</gtr:currCode><gtr:currCountryCode>China</gtr:currCountryCode><gtr:currLang>zh_CN</gtr:currLang><gtr:description>Studying the Tumour specific T cells in virus associated cancer</gtr:description><gtr:end>2022-04-02</gtr:end><gtr:fundingOrg>National Science Foundation China</gtr:fundingOrg><gtr:id>5D5F59A5-0907-4294-9D99-7C604BE090BA</gtr:id><gtr:outcomeId>58be8b3ce53eb2.36900943</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>China, People's Republic of</gtr:country><gtr:currCode>CNY</gtr:currCode><gtr:currCountryCode>China</gtr:currCountryCode><gtr:currLang>zh_CN</gtr:currLang><gtr:description>Anti-viral T cells in HIV infection</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Science Foundation China</gtr:fundingOrg><gtr:id>0A0F117D-A45A-4F90-96B6-2DA32080664B</gtr:id><gtr:outcomeId>5463744c863b54.70828584</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Flu vaccine for heterosubtypeic protection</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3931F921-B6F5-4B53-80DC-D0C1CC74E750</gtr:id><gtr:outcomeId>5463752fb67786.23043615</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>813590</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Human Immunology Unit = program title: Human Anti-viral T cells (1 of 10 groups in HIU)</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0F38FEBD-0AE1-4BFC-9684-FE789C6EB046</gtr:id><gtr:outcomeId>546370e577d8a6.23944246</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:description>Developing Research Capacity for West African Network for Prevention Trials</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Global Health Research Initiative (GHRI)</gtr:fundingOrg><gtr:id>D2A40C15-3187-4554-BAD8-AC01CB6C3BC5</gtr:id><gtr:outcomeId>546374e33f7147.46590456</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC capacity building studentships (Srinika Ranasinghe)</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5F008585-C4E3-4E92-8E38-BEC148921D16</gtr:id><gtr:outcomeId>546371b0e3eea2.07041035</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2005-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>213422</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Institutional Strategic Support Fund (WTISSF) , T-Cell Immunity to HBV associated HCC</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>60C6859C-6A55-45E6-A532-F19DBE579F11</gtr:id><gtr:outcomeId>545a3682c0d367.82419146</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Janssen Pharmaceutical - Characterising HBV specific T cells in HBV associated liver disease</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Janssen Biotech, Inc.</gtr:fundingOrg><gtr:id>856B8B36-802C-481C-9F3E-ABDB7929F016</gtr:id><gtr:outcomeId>58be89f2272344.87015373</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2800000</gtr:amountPounds><gtr:country>China, People's Republic of</gtr:country><gtr:currCode>CNY</gtr:currCode><gtr:currCountryCode>China</gtr:currCountryCode><gtr:currLang>zh_CN</gtr:currLang><gtr:description>The Impact of IFITM3 variants in influenza virus infection</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Science Foundation China</gtr:fundingOrg><gtr:id>ECCC79F5-5249-480A-8ED0-9B55969C6762</gtr:id><gtr:outcomeId>5463727ebee794.84849172</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>523348</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European FP7,EU FP7-HEALTH-2012-INNOVATION</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>4F7D5AB1-15A9-4598-84DF-3DCC1AD19D77</gtr:id><gtr:outcomeId>545a37f3ae6181.38956447</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>987001</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The use of human monoclonal antibodies to inform and enhance influenza vaccine virus selection</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4C423C70-FAC3-41B6-95E2-FD681A07E8D5</gtr:id><gtr:outcomeId>58be8aae0c9b88.02690773</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000000</gtr:amountPounds><gtr:country>China, People's Republic of</gtr:country><gtr:currCode>CNY</gtr:currCode><gtr:currCountryCode>China</gtr:currCountryCode><gtr:currLang>zh_CN</gtr:currLang><gtr:description>Immune responses in HBV associated HCC (Overseas co-applicant)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Ministry of Science and Technology (MOST)</gtr:fundingOrg><gtr:id>6FEB12E9-1717-456A-AF2A-F0C385CC42E1</gtr:id><gtr:outcomeId>546373e66cdd01.65362661</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1477000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>Human Anti-viral T Cells</gtr:description><gtr:end>2022-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1C6778C5-C228-4322-AD70-0C0A3B42A42F</gtr:id><gtr:outcomeId>58be8b93282774.01884929</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1107634</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The impact of IFTIM3 genetic variation on influenza virus infection, immune responses and disease outcome</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0E767676-33B7-4EB5-A391-2DAE46FA28D2</gtr:id><gtr:outcomeId>54637061c72dd2.64969012</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>412500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant: T cell in H5N1 infection</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E97AA4CD-436C-446C-B98D-AAA2E736B6E2</gtr:id><gtr:outcomeId>546371551515e4.10012163</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Janssen Pharmaceutical - Characterising HBV specific T cells in HBV associated liver disease</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Janssen Biotech, Inc.</gtr:fundingOrg><gtr:id>6C73A564-B400-42D3-8EF7-14F37EDD90CD</gtr:id><gtr:outcomeId>56c5cad455de32.18645058</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Peer review for funding agencies, Natural Science Foundation (ANR)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E9737410-96B0-4AD4-BB02-0A821F80B7F8</gtr:id><gtr:outcomeId>54634cfa73e350.17899444</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Peer review for funding agencies, Skokovo Foundation, Moscow, Russia</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EDE48D0A-EDE7-40BE-B3AE-7EB3C80FD61A</gtr:id><gtr:outcomeId>54634ea212bed0.66491655</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Peer review for funding agencies, The University of Washington Fred Hutchingson Cancer Research Centre AIDS Research (NIAID) program</gtr:description><gtr:geographicReach>South America</gtr:geographicReach><gtr:id>99533987-DEA4-4469-9200-5F69151662FB</gtr:id><gtr:outcomeId>54634d57430637.64239818</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Peer review for Medical Research Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>295C69D5-45FA-40C7-A502-FE6F19A28E39</gtr:id><gtr:outcomeId>546347ee3cc4b5.34075114</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Health and Medical Research Fund, peer review for funding agencies</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8C3171DE-1D74-459C-AD39-AA25D9366B08</gtr:id><gtr:outcomeId>5463489be73a61.26924617</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Peer review for funding agencies, Research Grants Council (RGC)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>DB67A0EC-58C5-4C1B-A089-DA1DF6143DC1</gtr:id><gtr:outcomeId>54634e257e8dd8.08692411</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Peptide containing new T cell epitopes, overlapping peptides spanning H5N1, and human H3N2 proteome</gtr:description><gtr:id>7E80DA13-6886-466D-B4BF-69C01AE646D0</gtr:id><gtr:impact>Cross reactive peptides could be used for study the impact of cross reactive T cell responses in Vaccine trails and human influenza infected patients.</gtr:impact><gtr:outcomeId>ctRf6d3wJo8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>T cell epitopes and overlapping peptides</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9EE39DE6-38E4-4D12-949D-A0E6E5AE8192</gtr:id><gtr:title>The role of CD8+ T-cell responses in the pathogenesis of HIV-2, a naturally contained human retroviral infection</gtr:title><gtr:parentPublicationTitle>Journal of Infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292540540153f0fec29df5f22db2aecf"><gtr:id>292540540153f0fec29df5f22db2aecf</gtr:id><gtr:otherNames>de Silva T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546212434081b3.10312641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E14F8A0F-F7FD-4913-B532-84529427F1DB</gtr:id><gtr:title>Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular and infection microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26344a360d7891001f628f2e62623fe5"><gtr:id>26344a360d7891001f628f2e62623fe5</gtr:id><gtr:otherNames>Pan Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2235-2988</gtr:issn><gtr:outcomeId>5a82dbd69b7ac0.18629508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9709B22-DCBD-42A3-8A6F-A72470C61661</gtr:id><gtr:title>KIR3DS1*0130108 isolated using full length sequence-based typing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a0f0639c6f6.88307995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6762D006-1E8F-445D-8BD0-FD105CA26615</gtr:id><gtr:title>Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients.</gtr:title><gtr:parentPublicationTitle>Liver international : official journal of the International Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1478-3223</gtr:issn><gtr:outcomeId>5459f06ab39f86.56375268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70CB17AB-9863-4241-BBAB-5AA6CD7A3377</gtr:id><gtr:title>The KIR3DS1*0130105 allele identified using high-resolution sequence-based typing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>54620ed6818759.82116974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E916E7CA-7669-4EA0-B201-FBAE95B698A6</gtr:id><gtr:title>HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6857832a949702b920fe517096cb5d33"><gtr:id>6857832a949702b920fe517096cb5d33</gtr:id><gtr:otherNames>Blais ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5459fc88b0b751.84923371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D87ABFE1-E3DD-4B10-AE88-017408BD7D8B</gtr:id><gtr:title>Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China.</gtr:title><gtr:parentPublicationTitle>Human immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17f6633e9d8a0b4804343fbc2df4165c"><gtr:id>17f6633e9d8a0b4804343fbc2df4165c</gtr:id><gtr:otherNames>Wang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0198-8859</gtr:issn><gtr:outcomeId>545a237f122232.01783933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A65E772D-4316-42D2-A2A7-CDDA55C9D40F</gtr:id><gtr:title>Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bccd0fd70584179d048b43693c7805b"><gtr:id>0bccd0fd70584179d048b43693c7805b</gtr:id><gtr:otherNames>Peng Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5628eaa42f1814.98980071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5804E7C9-69A0-4E7F-B758-9B22BE8DC310</gtr:id><gtr:title>Killer-cell immunoglobulin-like receptor gene 3DL1*077 isolated using long-range sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a3146bb3fc3.75359941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0138970F-E601-4677-9848-D0F382D5F4AD</gtr:id><gtr:title>A novel full length KIR3DL1*0070103 identified by molecular typing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a280de319c5.56148642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D822537C-260A-4D62-A08D-B58BB8BA3EAA</gtr:id><gtr:title>A 2 amino acid shift in position leads to a substantial difference in the pattern of processing of 2 HIV-1 epitopes.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9324b0be55d7eb2d2992e62ffceeb4e"><gtr:id>c9324b0be55d7eb2d2992e62ffceeb4e</gtr:id><gtr:otherNames>Culshaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>5458acd857b7a4.92642343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>230642E8-D872-4126-AFD0-C2DAC8619679</gtr:id><gtr:title>A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0c6b9b627239f85e603ce8f8de6ade"><gtr:id>3d0c6b9b627239f85e603ce8f8de6ade</gtr:id><gtr:otherNames>Zhang YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b6a32e03e864.30417144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F5F1939-C2A4-440B-AD68-70DFE40BE1A7</gtr:id><gtr:title>HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma.</gtr:title><gtr:parentPublicationTitle>Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9f7df13cab6b06033afc0291664407"><gtr:id>2d9f7df13cab6b06033afc0291664407</gtr:id><gtr:otherNames>Wang RZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1672-0733</gtr:issn><gtr:outcomeId>58b6a32d775d66.37254618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BE9C8A8-ECF0-40BD-99D1-04DFC7CB1BC1</gtr:id><gtr:title>Apoptotic bone marrow CD34+ cells in cirrhotic patients.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b62b7e309a394cf71ce5f49a7c50db5"><gtr:id>4b62b7e309a394cf71ce5f49a7c50db5</gtr:id><gtr:otherNames>Dang SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>5459faa3912e84.04084781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82785776-2CE2-460C-AB6C-A3819BB7FB2D</gtr:id><gtr:title>Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>545a09486d6c93.01928238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A51F1AF1-32D7-4C2E-A7B2-59A4E271BA76</gtr:id><gtr:title>Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6728b659ca9047957546c2994120446a"><gtr:id>6728b659ca9047957546c2994120446a</gtr:id><gtr:otherNames>Wilkinson TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_13983_23_22286307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5F6C5F1-9014-4D29-A79C-81C59FAC8638</gtr:id><gtr:title>HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d86b50b64e61e0fee42ac950781ea420"><gtr:id>d86b50b64e61e0fee42ac950781ea420</gtr:id><gtr:otherNames>Rai MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5458fd249dcdf8.57484231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AD405A3-C345-4FF1-838E-648DABE5F6A0</gtr:id><gtr:title>Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f9af1eff0083b6215f6f76b0e99a74c"><gtr:id>3f9af1eff0083b6215f6f76b0e99a74c</gtr:id><gtr:otherNames>Powell TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_13983_23_22080094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE227DEA-EE47-4C12-AB85-0D307251E7DA</gtr:id><gtr:title>Description of a novel KIR3DL1*0050104 allele identified using sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a31cbe1b074.53971460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A917BD6-4BBE-410A-A4A0-F2178CCB27A3</gtr:id><gtr:title>Full-length genomic sequence of a new KIR3DL1*0150203 allele.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a31cb9945f1.58671620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>729A52E5-22F8-4A5D-A8A3-AB0FA8E4BB2A</gtr:id><gtr:title>Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7cdc53e4d61940698b236b86f46c2a7"><gtr:id>b7cdc53e4d61940698b236b86f46c2a7</gtr:id><gtr:otherNames>Denney L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54621cc8ecf8e2.55690139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF97B31-4542-4CC9-A2DA-495F07939C04</gtr:id><gtr:title>Detection of a novel killer-cell immunoglobulin-like receptor allele&amp;nbsp;-&amp;nbsp;KIR3DL1*0150207&amp;nbsp;-&amp;nbsp;in Asian individuals.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>54620db9ccf1c6.82947673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>276B1361-6DC2-46E6-B459-CE9EB6412EAB</gtr:id><gtr:title>Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2f2bd7f336da8c018723aeaf0de7f58"><gtr:id>f2f2bd7f336da8c018723aeaf0de7f58</gtr:id><gtr:otherNames>Dushek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>5459f8bb8f9695.20809696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>864F5A9A-B03A-4315-8518-02AFFA7E40E0</gtr:id><gtr:title>Report of a novel KIR3DS1*0130104 allele discovered using advanced molecular techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a31cb684eb0.02430046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B11DF67A-1294-42DD-929F-C7E6CA40BF65</gtr:id><gtr:title>Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51f09ae31d36a289662577675db5ec78"><gtr:id>51f09ae31d36a289662577675db5ec78</gtr:id><gtr:otherNames>Jayasooriya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5628eaa4064aa1.37647463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5266AD8F-0E2C-4731-95DE-7F2860936E52</gtr:id><gtr:title>Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d09a00d7c724d63247a15b7e5419d9c5"><gtr:id>d09a00d7c724d63247a15b7e5419d9c5</gtr:id><gtr:otherNames>De Santo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>54621f9410bc53.53391318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>371D9976-F65E-45EC-91CB-74D106F69EC1</gtr:id><gtr:title>Reply to &amp;quot;Failure to detect production of IL-10 by activated human neutrophils&amp;quot;</gtr:title><gtr:parentPublicationTitle>Nature Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d09a00d7c724d63247a15b7e5419d9c5"><gtr:id>d09a00d7c724d63247a15b7e5419d9c5</gtr:id><gtr:otherNames>De Santo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>54621b34258e11.33890875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>285D4C5D-128E-41D7-B825-D7709F670E1A</gtr:id><gtr:title>Identification of KIR3DL1*0150208 using long-range sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a24d6a6e5d8.84557946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A6915D-7A22-42D5-A270-BA390F7FA038</gtr:id><gtr:title>Detection of a novel KIR3DL1*0150210 allele by sequencing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>5637749d101c09.87733727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AD8B2A-ED9C-40B3-90CE-38969DB5F5C7</gtr:id><gtr:title>Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5459fe686e66b3.35463920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09FFCE31-705B-409D-8AB4-DAEF0C52B6D1</gtr:id><gtr:title>T-cell immune responses and asymptomatic H5N1 influenza infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01bcc1df37188e346c28d8dd16b4d1b7"><gtr:id>01bcc1df37188e346c28d8dd16b4d1b7</gtr:id><gtr:otherNames>Epstein S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5459fd8edc7260.76383002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4F6EFAC-0ED6-473E-BBB2-F758D8AC2F7B</gtr:id><gtr:title>The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>545a280e1b8cb8.61812439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D65A2E9-C585-49B1-8E2D-39AE71970603</gtr:id><gtr:title>Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0c6b9b627239f85e603ce8f8de6ade"><gtr:id>3d0c6b9b627239f85e603ce8f8de6ade</gtr:id><gtr:otherNames>Zhang YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>545798faa65c88.69621320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653C95C7-6C00-4796-8B10-162BC915B9F3</gtr:id><gtr:title>Identification of the KIR3DL1*0050105 allele by sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a250617f5a4.18358199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F53B724-C0EA-430E-8726-93146D771406</gtr:id><gtr:title>High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5459f26081d7a3.15734400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F0339A4-689F-48A2-9DF4-39EDBF9E9733</gtr:id><gtr:title>Pathogenesis of influenza: virus-host interactions.</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfddea19157463d05f34525ba5b1459e"><gtr:id>dfddea19157463d05f34525ba5b1459e</gtr:id><gtr:otherNames>Godlee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn><gtr:outcomeId>54621b3449e985.43103076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA540FD5-2C09-4E90-A90C-F1622C576A4F</gtr:id><gtr:title>A novel KIR3DS1*0130107 allele isolated by sequencing from an Asian donor.</gtr:title><gtr:parentPublicationTitle>International journal of immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-3121</gtr:issn><gtr:outcomeId>545a0f068b3962.85668197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D923805E-4C3D-474E-A8FC-E9CA6B49E15C</gtr:id><gtr:title>Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fef47854e58eb3013f9aca5dc3e145ba"><gtr:id>fef47854e58eb3013f9aca5dc3e145ba</gtr:id><gtr:otherNames>Madsen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545a0aeebdadf7.90873811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85C5B691-9272-47DB-B327-2F096EB49ADB</gtr:id><gtr:title>Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c22f4dff265ae6494e8c07966c893b13"><gtr:id>c22f4dff265ae6494e8c07966c893b13</gtr:id><gtr:otherNames>Dong T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5458ea3b639d03.59924763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECBF87B-9577-4D8B-BC7F-043F28AD3887</gtr:id><gtr:title>Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5628e9a5d5f776.81002964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F8AD656-6D3A-46DE-9DD6-8092E9457720</gtr:id><gtr:title>Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6a9149bbfa93ced1ec129cdcdfb0084"><gtr:id>d6a9149bbfa93ced1ec129cdcdfb0084</gtr:id><gtr:otherNames>Jiang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn><gtr:outcomeId>58b6a32dd9f776.43285902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACDEA65E-72F3-484C-95C6-BDB8EE6E7F79</gtr:id><gtr:title>Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome.</gtr:title><gtr:parentPublicationTitle>Archives of gynecology and obstetrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42503e20e5685881e24780cc93d5a243"><gtr:id>42503e20e5685881e24780cc93d5a243</gtr:id><gtr:otherNames>Alifu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0932-0067</gtr:issn><gtr:outcomeId>5a82dce9307657.07897669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BA8472F-92F8-4E5B-87BE-13E11C980397</gtr:id><gtr:title>Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07fefc16726e8220ca1003792597d1ee"><gtr:id>07fefc16726e8220ca1003792597d1ee</gtr:id><gtr:otherNames>Nakaya HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58b6a32e7f2880.61988323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF902A56-711A-408E-A5F3-7DFDF6BBB854</gtr:id><gtr:title>Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ae9c03e19152fa146debeb3e0a9814"><gtr:id>c0ae9c03e19152fa146debeb3e0a9814</gtr:id><gtr:otherNames>Leligdowicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5458ecdbb918f4.57810352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A88B5AFF-0BE7-4150-9597-97C6CCFAAF0C</gtr:id><gtr:title>Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bbb2be0454170f93b420b8b074fb699"><gtr:id>9bbb2be0454170f93b420b8b074fb699</gtr:id><gtr:otherNames>Makvandi-Nejad S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5a6f2e57258e85.84009268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3180CAFA-A2EC-4F95-BC18-E77B3A37FC50</gtr:id><gtr:title>Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-? contributes to modulate immune responses.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/650ef185c9327b64a4119aa15ad3bbfb"><gtr:id>650ef185c9327b64a4119aa15ad3bbfb</gtr:id><gtr:otherNames>Germain C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5459fb585275c1.47689807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E7CA1F-D642-47B8-AFAE-85D5295E559B</gtr:id><gtr:title>CD8+ cytotoxic T lymphocytes in human influenza virus infection.</gtr:title><gtr:parentPublicationTitle>National science review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c22f4dff265ae6494e8c07966c893b13"><gtr:id>c22f4dff265ae6494e8c07966c893b13</gtr:id><gtr:otherNames>Dong T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2053-714X</gtr:issn><gtr:outcomeId>56376e044bc5f2.36904842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4686478-2DEE-4CF5-8E67-4144E54B2846</gtr:id><gtr:title>Report of a novel activating killer-cell immunoglobulin-like receptor allele 3DS1*078 identified using sequence-based typing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a0f0662d6f1.08730217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D6FC936-9EED-4B71-9ACF-2536267AD702</gtr:id><gtr:title>Direct relationship between virus load and systemic immune activation in HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ae9c03e19152fa146debeb3e0a9814"><gtr:id>c0ae9c03e19152fa146debeb3e0a9814</gtr:id><gtr:otherNames>Leligdowicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>545a04e83292c0.98265517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C21051F-4A29-45BC-97F7-2010E72DED5D</gtr:id><gtr:title>High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6857832a949702b920fe517096cb5d33"><gtr:id>6857832a949702b920fe517096cb5d33</gtr:id><gtr:otherNames>Blais ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5459031b0c8553.37008787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECF35467-E5D6-4763-8A00-92C145B5A64F</gtr:id><gtr:title>Multilayered defense in HLA-B51-associated HIV viral control.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5458eb0dedc4b6.21522281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC362FB-D131-4152-BBCF-191B7AF02CF8</gtr:id><gtr:title>A novel KIR3DL1*0070104 allele found in individuals from Asia.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a3146922f25.07361356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90B1A4D6-AB43-4192-BB06-3602C2899E5B</gtr:id><gtr:title>A statistical approach to determining responses to individual peptides from pooled-peptide ELISpot data.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16b26d8a504fa824577d7c9a7ea4c286"><gtr:id>16b26d8a504fa824577d7c9a7ea4c286</gtr:id><gtr:otherNames>Str?m P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>58b6a32e2f41c2.20682524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63D3016E-B724-4CB8-B232-638B7791BFDD</gtr:id><gtr:title>Defining ELISpot cut-offs from unreplicated test and control wells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74808776ca4e7eea22bba634ee529024"><gtr:id>74808776ca4e7eea22bba634ee529024</gtr:id><gtr:otherNames>Alexander N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>pm_13983_23_23500146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>968F1F2E-F23B-4783-9CE5-8FD78E3D9ACD</gtr:id><gtr:title>The antiviral efficacy of HIV-specific CD8? T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b17017d77435c1a577520bb0831fcac"><gtr:id>4b17017d77435c1a577520bb0831fcac</gtr:id><gtr:otherNames>Ranasinghe SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5459ff38219979.99675764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59FE1116-802A-4535-B797-C545F07D4890</gtr:id><gtr:title>Characterization of an HLA-C-restricted CTL response in chronic HIV infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193c31d7dd0cbcc9e1cc55671bfe06d2"><gtr:id>193c31d7dd0cbcc9e1cc55671bfe06d2</gtr:id><gtr:otherNames>Makadzange AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>545a04e8859cf4.15939109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78714F17-2060-46BF-BC14-E995ECEFFD50</gtr:id><gtr:title>Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaa9f13165e076c2f67773a1f8ff7fd5"><gtr:id>eaa9f13165e076c2f67773a1f8ff7fd5</gtr:id><gtr:otherNames>Dang S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>545a0f943c74b8.53080004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F3EA037-B734-41A3-A9DB-C7B340D67335</gtr:id><gtr:title>Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f9af1eff0083b6215f6f76b0e99a74c"><gtr:id>3f9af1eff0083b6215f6f76b0e99a74c</gtr:id><gtr:otherNames>Powell TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13983_23_23658773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D070162E-7C83-41EB-AAD4-1935BC666CEE</gtr:id><gtr:title>HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9918cceae6812ca331bc427f3ed82a8"><gtr:id>e9918cceae6812ca331bc427f3ed82a8</gtr:id><gtr:otherNames>Rajapaksa US</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54590493bb0a89.79807658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>230B3F10-9A6F-4C70-954F-0B6FEE476DFF</gtr:id><gtr:title>Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7171b7961f3deba4f707f92470fada"><gtr:id>6c7171b7961f3deba4f707f92470fada</gtr:id><gtr:otherNames>Lillie PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_13983_23_22441650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55AF6D6C-488A-4CE7-B74D-178CA85928A3</gtr:id><gtr:title>The identification of a killer cell immunoglobulin-like receptor 3DL1*0150209 in an Asian population using molecular techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>58b6a371895176.97612788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78606B04-8F2F-4FE4-898D-71E90162BB10</gtr:id><gtr:title>Full length KIR3DS1*0130110 allele isolated by SBT.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a0f06109ef8.44963736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA54C7BB-EA1A-4B97-BD18-58D03AEC3ADE</gtr:id><gtr:title>The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf15dad4439b15c78ef2845f4adcd3"><gtr:id>7ecf15dad4439b15c78ef2845f4adcd3</gtr:id><gtr:otherNames>Jallow S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5628e8fe34fca9.31701761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D171073A-006B-4D73-81A9-258A80D3E350</gtr:id><gtr:title>A novel full-length KIR3DS1*0130106 allele identified by sequencing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a1860864064.89404205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29E0CF68-8E05-4165-8291-6151DF1100BF</gtr:id><gtr:title>M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02aa2ebb10d042b908ae932541a85e1"><gtr:id>f02aa2ebb10d042b908ae932541a85e1</gtr:id><gtr:otherNames>Cole SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a6f2f634c4570.41963812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB618AE4-6961-4FC3-88F2-40170050DFC6</gtr:id><gtr:title>Multiple T-cell responses are associated with better control of acute HIV-1 infection: An observational study.</gtr:title><gtr:parentPublicationTitle>Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fbee13de0f083ea68ae008d704b0ddd"><gtr:id>3fbee13de0f083ea68ae008d704b0ddd</gtr:id><gtr:otherNames>Sun J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0025-7974</gtr:issn><gtr:outcomeId>58b6a32e4e6405.30957402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF488D6F-54B7-40FA-BE71-4F8BA7A362A1</gtr:id><gtr:title>Combinatorial HLA-peptide bead libraries for high throughput identification of CD8? T cell specificity.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>545a237f3d7745.61327184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F498D49-BEEE-4DD1-9A24-128CB91EF757</gtr:id><gtr:title>Short communication: broader T cell responses directed against human immunodeficiency virus type 1 in infected Chinese individuals through blood-borne transmission in comparison with mucosal transmission.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33877dd64ee6d03f2f603a69ed842ce8"><gtr:id>33877dd64ee6d03f2f603a69ed842ce8</gtr:id><gtr:otherNames>Zhou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>5458fec9111033.01388323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75138BD0-BDFE-40EC-B68A-9137858A91E1</gtr:id><gtr:title>Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8T cell response.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9324b0be55d7eb2d2992e62ffceeb4e"><gtr:id>c9324b0be55d7eb2d2992e62ffceeb4e</gtr:id><gtr:otherNames>Culshaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a82dbd6723264.04588490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>039B02E6-BCBA-4147-AFCC-8013AB641EB2</gtr:id><gtr:title>Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8428373b18bd0a52b3e33311d03b3321"><gtr:id>8428373b18bd0a52b3e33311d03b3321</gtr:id><gtr:otherNames>Lee LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5458eecb35e3c2.54269321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>143DFA54-2912-4AC6-B38A-419E18541BB7</gtr:id><gtr:title>Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbfd9fb6e692d07596464ca94848bf67"><gtr:id>fbfd9fb6e692d07596464ca94848bf67</gtr:id><gtr:otherNames>Chen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>5458fc1678a766.87089426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DA7D4FC-78F5-450A-B726-21A1DF1CE1CA</gtr:id><gtr:title>Long-range sequencing revealed a new KIR3DL1*0150204 allele in 20 individuals of Asian descent.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545a31cbbd6760.59006075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8DEDBA1-A77E-474F-AFC4-4A532B714638</gtr:id><gtr:title>Identification of KIR3DL1*0050103 by the sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>545b7c42915946.24580044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B94C6F6D-7D78-43E0-B477-F06F4386B145</gtr:id><gtr:title>Identification of KIR3DL1*0200101 by long-range sequence-based techniques.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>54620ed6ac5c06.09844232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>017BC8B2-1FBC-4AE3-80E0-94CAF07F3884</gtr:id><gtr:title>Viruses transfer the antiviral second messenger cGAMP between cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e491ba8e5b16c64ec3cb8b381ebef5a"><gtr:id>3e491ba8e5b16c64ec3cb8b381ebef5a</gtr:id><gtr:otherNames>Bridgeman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58b6a3a3769d23.93050646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B22F294D-7287-4529-BAC1-20BD2A5803EA</gtr:id><gtr:title>Two novel KIR3DL1 alleles, 3DL1*0150205 and 3DL1*0150206, identified by full-length DNA sequencing.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>54620f71c29e96.69318958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27EF7B3C-53B7-4EEB-A561-9E089C75FB6E</gtr:id><gtr:title>Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7565951b0f0ca59c1de7afa1663bc589"><gtr:id>7565951b0f0ca59c1de7afa1663bc589</gtr:id><gtr:otherNames>Dung NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a017297efb9.79990164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846A6513-BA83-47A2-8E78-27D71C95D361</gtr:id><gtr:title>Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545a0bea8691a4.16793099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>159800BC-0FE9-4201-B63E-B52F2138A3A0</gtr:id><gtr:title>Revisiting the effect of acute P. falciparum malaria on Epstein-Barr virus: host balance in the setting of reduced malaria endemicity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51f09ae31d36a289662577675db5ec78"><gtr:id>51f09ae31d36a289662577675db5ec78</gtr:id><gtr:otherNames>Jayasooriya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5459074da44da0.99413888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A7778F5-DAC3-4ECB-A367-A53A2AAD86F5</gtr:id><gtr:title>Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A*30-B*13-C*06-positive patients.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5628e9a615fd56.21471232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4FD490D-8820-4D2B-96F5-01C0BD6AAAC8</gtr:id><gtr:title>The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5462185eb2e189.18802179</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001046</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>